<html xmlns="http://www.w3.org/1999/xhtml"><head>
        <meta http-equiv="Content-Type" content="text/html; charset=utf-8">
        <meta name="viewport" content="width=device-width, height=device-height, initial-scale=0.5, minimum-scale=0.5, user-scalable=yes, maximum-scale=2.0, target-densitydpi=device-dpi" />
				<meta name="robots" content="all"/>
        <meta name="description" content="description">
        <meta name="keywords" content="">
        <title>Page 249 - MIMS April 2020 E4</title>
<style type="text/css">
<!--
body {
	margin-left: 0px;
	margin-top: 0px;
	margin-right: 0px;
	margin-bottom: 0px;
}
  
#container {margin:50px auto;padding:0px;width:910px;}
#left-button{ width:90px; height:100%;float:left }
#middle{ width:730px; margin:0px; float: left;}
#right-button{ width:90px; float:left;}
html, body, div, ul, li, dl, dt, dd, h1, h2, h3, h4, h5, h6, form, input, dd,select, button, textarea, iframe, table, th, td { margin: 0; padding: 0; }
img { border: 0 none; displayblock}
span,ul,li,image{ padding:0px; margin:0px; list-style:none;}
#top-title{ width:714px; margin-bottom:10px; float:left; padding:0px 8px}
#top-title2{ width:320px;  float:right;}
#content{ width: 730px; float:left;float:left;word-wrap: break-word;}
#content-top{ width:730px; background-image:url(images/top_bg.jpg); height:56px; background-repeat:no-repeat; float:left;}
#content-top1{ width:70%; padding:16px 0px 0px 30px; font-family:Arial, Helvetica, sans-serif; font-size:24px; color:#636363;float:left;}
#content-top2{ width:60px; float:right; padding:25px 30px 0px 0px;font-family:Arial, Helvetica, sans-serif; font-size:11px; color:#2f2f2f; font-weight:bold; text-align:right}
#content-middle{ width:730px; background-image:url(images/middle_bg.jpg); background-repeat:repeat-y;float:left;}
#content-middle1{ width:475px; padding:25px 0px 25px 35px; font-family:Arial, Helvetica, sans-serif; font-size:12px; color:#636363; line-height:150%;float:left;}
#content-middle2{  padding:7px; float:right; margin:25px 35px 0px 0px; border:solid 1px #c8c8c9; background-color:#FFF; text-align:center}
#content-bottom{ width:730px; background-image:url(images/bottom_bg.jpg); background-repeat:no-repeat; height:58px;float:left;}
#content-bottom2{ width:110px; height:42px; margin:0px auto; padding-top:4px;}
#input{ width:58px; height:20px; background-color:#FFF; border:solid 1px #dfdfe0; color:#636363; text-align:center; font-size:11px;}
.font1{ font-family:Arial, Helvetica, sans-serif; font-size:10px; color:#2f2f2f;}
.font1 a:link{
	text-decoration: none;
    color:#2f2f2f;

}
.font1 a:visited{
	text-decoration: none;
    color:#2f2f2f;
	
}
.font1 a:hover{
	color: #2f2f2f;
	text-decoration: underline;

}



.text-container {
padding: 20px;
color: #333;
margin-top: 24px;
line-height: 22px;
border-top-left-radius: 3px;
border-top-right-radius: 3px;
}

.use-as-video {
float: right;
padding-left: 20px;
}
.cc-float-fix:before, .cc-float-fix:after {
content: "";
line-height: 0;
height: 0;
width: 0;
display: block;
visibility: hidden;
}
.use-as-video-img {
cursor: pointer;
position: relative;
width: 320px;
height: 180px;
}
.use-as-video-title {
font-size: 15px;
font-weight: bold;
color: #000000;
padding-bottom: 5px;
}
-->
</style>
<script type="text/javascript">
<!--
function MM_preloadImages() { //v3.0
  var d=document; if(d.images){ if(!d.MM_p) d.MM_p=new Array();
    var i,j=d.MM_p.length,a=MM_preloadImages.arguments; for(i=0; i<a.length; i++)
    if (a[i].indexOf("#")!=0){ d.MM_p[j]=new Image; d.MM_p[j++].src=a[i];}}
}

function MM_swapImgRestore() { //v3.0
  var i,x,a=document.MM_sr; for(i=0;a&&i<a.length&&(x=a[i])&&x.oSrc;i++) x.src=x.oSrc;
}

function MM_findObj(n, d) { //v4.01
  var p,i,x;  if(!d) d=document; if((p=n.indexOf("?"))>0&&parent.frames.length) {
    d=parent.frames[n.substring(p+1)].document; n=n.substring(0,p);}
  if(!(x=d[n])&&d.all) x=d.all[n]; for (i=0;!x&&i<d.forms.length;i++) x=d.forms[i][n];
  for(i=0;!x&&d.layers&&i<d.layers.length;i++) x=MM_findObj(n,d.layers[i].document);
  if(!x && d.getElementById) x=d.getElementById(n); return x;
}

function MM_swapImage() { //v3.0
  var i,j=0,x,a=MM_swapImage.arguments; document.MM_sr=new Array; for(i=0;i<(a.length-2);i+=3)
   if ((x=MM_findObj(a[i]))!=null){document.MM_sr[j++]=x; if(!x.oSrc) x.oSrc=x.src; x.src=a[i+2];}
}
//-->
</script>
</head>

<body onload="MM_preloadImages('images/next2.png','images/previous2.png')">
<div id="container">
<div id="left-button">
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p><a href="page248.html"><img src="images/previous_big.png" width="90" height="80" /></a></p>
</div>
<div id="middle">
  <div id="top-title"><span class="font1">Basic HTML Version</span>
    <div id="top-title2">
      <table width="100%" border="0" align="right" cellpadding="0" cellspacing="0">
        <tr>
        	<td width="66%"> </td>
          <td width="35%" style="display:none" align="right"><img src="images/content.png" width="19" height="16" /></td>
          <td width="31%" style="display:none" class="font1"><a href="">Table of Contents</a></td>
          <td width="6%"><img src="images/view.png" width="19" height="16" /></td>
          <td width="28%" class="font1"><a href="../../MIMS April 2020 E4.html#p=249">View Full Version</a></td>
        </tr>
      </table>
    </div>
  </div>
  <div id="content">
     <div id="content-top">
        <div id="content-top1">Page 249 - MIMS April 2020 E4</div>
        <div id="content-top2">P. 249</div>
     </div>
     <div id="content-middle">
     	
     	  <div class="text-container">
    <div class="use-as-video cc-float-fix">
      <a style="text-decoration: none;" href="../../MIMS April 2020 E4.html#p=249"><img src="../thumb/249.jpg" /></a>
    </div>

    <p class="use-as-video-title"></p>
    <pre style="white-space:pre-line"><code>212 / 2020-04                                                          Urinary System - 16.1 / 16.2
   PHARMA-Q FUROSEMIDE INJECTION, Pharma-Q  (S3) TABS. 43/18.1/1042, 1043  (S3) TABS. 28/18.1/0292, 0293, 0294
   Furosemide.                  3000185-001: 5 mg, 30, R140,70  820369-004: 2,5 mg, 30, R194,42
   Indications: Oed.of card./hepat./ren.origin, ac. pulm. oed., cerebr.  3000186-001: 10 mg, 30, R152,65  820377-007: 5 mg, 30, R215,00
   oed., forc.diures.           Dosage: Essent.hypertens: Init: 2,5 mg/day. Usual maint: 2,5 mg/  820385-018: 10 mg, 30, R233,10
   (S3) INJ. 32/18.1/0194, 29/18.1/0664. 10 mg/ml  day. May be incr.to 5 mg/day if eff.insuff.  Dosage: Essent.hypertens: Init: 2,5 mg/day. Usual maint: 2,5 mg/
   899127-002: 20 mg/2 ml, 10x2 ml, R24,57  Oed.of card.& ren.origin: Init: 5 mg/day. Usual maint: 5 mg/day.   day. May be incr.to 5 mg/day if eff.insuff.
   703589-001: 50 mg/5 ml, 10x5 ml, R109,43  May be incr.up to 20 mg/day depend. on sev.if eff.insuff. Up to 40 mg   Oed.of card.& ren.origin: Init: 5 mg/day. Usual maint: 5 mg/day.
   Dosage: IM/IV. IV rate not to exceed 4 mg/min. Adults:   has been admin.in indiv.cases.  May be incr.up to 20 mg/day depend.on sev.if eff.insuff. Up to 40 mg
   Recomm.20-50 mg slow IV repeat.aft.not less than 2 hrs.if need.  Contraindications: Ren.fail.with anur., hepat. fail., pregn.& lactat.,   has been admin.in indiv.cases.
   Childr: Usual.0,5-1,5 mg/kg bm.  sulfonylurea hypersens., hypovolaem./-natraem./-kalaem., sev.mic-  Contraindications: Ren.fail.with anur., hepat. precoma & coma,
                   nd
   Pulm.oed: 40 mg slow IV follow.by 2  dos.1 hr later if need. May   turit. disords., childr.12 yrs.or young.  pregn.& lactat., sulfonylurea hypersens., hypovolaem./-natraem./-
   be incr.to 80 mg.            Side effects: Freq: Constip., N&V, headache, dizzin. Less freq:   kalaem., sev. micturit.disords., childr.12 yrs.or young.
   Contraindications: Sulphonam.hypersens., anur./ ren. fail.due to   Water & electrol.disturbs. depend. on dos.& durat.esp.with limit.  Side effects: Water & electrol.disturbs.depend. on dos.& durat.
   nephrotoxic./hepatox.drugs, ren. fail.assoc.with hepat.coma, pre-  salt intake, hypokalaem., hyponatraem., hypochloraem. alkalos., decr.  esp.with limit.salt intake, electrol.& vol. defic.incl.headache/dizzin./
   comatose states assoc.with hepat.cirrhos., safety in lactat.not est.  erythrocyte/leucocyte/platelet counts, hypotens., GI haemorrh., dry   weakn./loss of appet. /cramps esp.init.& in elderly pts., hypotens.,
   Side effects: Fluid & electrol.imbal.incl. hyponatraem. /hypokalaem./  mouth., allerg. skin reacts., photosens., limb paraesthes., vis. disturbs,   confus.states, cerebr.ischaem., GI disturbs., poss. rise in bld.gluc.,
   hypochloraem. alkalos., allergy, nausea, diarrh., vis.disturbs., dizzin.,   ototox. Freq.unknown: Thromboembol. complicats., card./cerebr.is-  incr.urine prod.in pts.with urin. obstruct. may lead to urin.retent./
   headache, pancreatit., photosens., skin rash., hypersens.reacts., hy-  chaem, diarrh., incr.bld. urea & creatin., confus.states, poss.rise in bld.   bladd.distent., decr.bld.corpusc.constit., low.K -lev.esp.in low K -di-
                                                                                        +
                                                                                 +
   potens., bld.dyscras., hepat. dysfunct., cholestat.jaund., paraesthes.,   gluc, incr. in Gamma-GT, alter.bld.gluc./lipid metabol.  et/chron.liv.disords., allerg.skin reacts., photosens., dry mouth, limb
   tinnit. & deafn.esp.high dos., glucosur., hyperglycaem., hyperuricaem.,   Warnings and special precautions: Monit. electrol.bal./vol.de-  paraesthes., vis. disturbs.
   incr.Ca ren.excret., ren. stone format.in preterm infts.  plet., monit.pts.with hyperuricaem. & gout tend., incr.urine prod.in pts.   Special precautions: Monit.electrol.bal./gluc /uric acid/creatin.&
   Special precautions: Pregn., cross.placent. barrier, excret.in breast   with urin.obstruct.may lead to urin.retent./bladd. distent., lact.intol.,   lipid lev.reg.dur.longt.ther., monit.pts.with hyperuricaem.& gout tend.,
   milk, jaund.infts., monit. fluid & electrol.imbal.esp.in pres.of vomit./  monit.gluc./uric acid/creatin.& lipid lev.reg.dur.longt.ther., carbo-  carbohydr. metab.monit.recomm.in latent/ manifest. diab.mellit.
   dur. parent. fluid ther., may precipit.gout attacks, prostat. hypertrophy,   hydr.metabol. monit. recomm.in latent/manifest. diab.mellit., elderly  Drug interactions: With concom.card.glycosid., K &/Mg defic.poss.
                                                                                   +
   micturit.impairm., concom. ototox. meds.  Interactions: With concom.card.glycosid., K &/ Mg defic.poss.incr.  incr.sens.of card.musc.to digit., kalidiuret. eff.of mineralo-& glucoster./
                                                   +
   Drug interactions: Poss.enhanc.cephalospor./ aminoglycoside   sens.of card.musc.to digit., kalidiuret. eff.of mineralo-& glucoster./  laxat. poss.incr., NSAID’s may reduc.eff., eff.of antihypertens. poss.
   nephrotoxic., poss.reduc.clinic.eff. with phenytoin & indomethacin.  laxat. poss. incr., NSAID’s may reduc.eff., eff.of antihypertens. poss.   potent., concom.ACE-inhibit. may result in excess.BP reduct., antidia-
   PURESIS, (Aspen Pharmacare: Pharma) Pharmacare  potent., concom.ACE-inhibit.may result in excess. BP reduct., antidia-  bet.meds. act. reduc., potent.damag.eff.of aminoglycoside/ cisplat.&
   Furosemide.                  bet.meds.act.reduc., potent. damag.eff.of aminoglycoside/cisplat.&   cephalospor., act.of curare musc.relax. & theophyll.potent., decr.arter.
   Indications: Ascites due to liv.cirrhos./ mechan. obstruct.or CF, prev.  cephalospor., act.of curare musc.relax.& theophyll. potent., decr.arter.  respons.to press. agents, incr.salicylate toxic.with high dos. salicylat.,
   oligur.progress.to complete anuria, card.oed., mild.to mod.hyper-  respons.to press.agents, incr. salicylate toxic.with high dos.salicylat.,   poss.reduc.eff.with cholestyramine.
   tens., oed.dur. last 3 mnths pregn.(pre-eclampt.toxaem.& eclamps.)  poss. reduc. eff.with cholestyramine., incr.risk of dysrhythm. assoc.
   (S3) TABS. H/18.1/185.       with hypokalaem.with concom. antidysrhythm.meds., eff.of concom.
   758272-006: 40 mg, 30, R26,24  anticoags. decr., incr.Li toxic., probenecid decr.act.  16.2  Anti-diuretics
   758272-014: 40 mg, 250, R218,73  SANDOZ INDAPAMIDE 2,5, Sandoz
   Dosage: Init. 1-3 tabs. Maint. ½-1 tab.dly.                DDAVP (MDR Listing)
   Contraindications: Hepat.coma, electrol. deplet., incr.azotaem.&   Indapamide.  MINIRIN MELT (MDR Listing)
                                Indications: Mild to mod.hypertens.
   oligur.dur.treatm., lactat. women
   Side effects: Dermatit., paraesth., blurr.vis., dizzin., pancreatit.,   (S3) TABS. Z/7.1/203.  DDAVP, Ferring [P/S] &
   photosens., postur.hypotens., headache, N&V, diarrh., bld.dyscras.,   831026-006: 2,5 mg, 30, R26,04  Desmopressin.
   asymptomat. hyperuricaem., gout & diabet.precipitat., decr.ser. Ca   Dosage: 1 tab.dly.pref.in the morn. Further reduct.in BP in combin.  Indications: Symptomat.short-term treatm.of prim.noct. enures.
   with result.tetany, dehydrat.& reduc.bld.vol., electrol. disturbs., hepat.  with other antihypertens.  in young & adult pts. (childr. old.than 5 yrs) who have norm.abil.to
   dysfunct., cholestat. jaund., tinnit., deafn.  Contraindications: Sev.hepat.insuffic., safety in pregn.& childr.  conc.urin. Diagn.centr.diabet.insipid., treatm.vasopressin sensit.centr.
   Special precautions: Only for select.pregn.cases & for short per.,   not est.   diabet.insipid., posthypophysect. polyur.& polydips., ren.funct.test.
   nephrotox.with concom. cephaloridine, perman.deafn.with con-  Side effects: Hyperglycaem.& glycosur.in diab. & other suscept.  (S4) NAS.SPRAY, [P/S] U/18.2/99. 0,1 mg/ml.
   com.ototox. meds., prostat.hypertrophy, imp.micturit., imp. hepat.   pts., hyperuricaem., may precipit. gout, electrol.imbal., GI disturbs.,   837555-019: 10 µg/spray, 5 ml, R1 017,98
   /ren.funct., porphyr.        headache, dizzin., photosens.reacts., postur.hypotens., paraes-  Dosage: Noct.enures: Indiv. Dos.varies betw. 10-20 µg given at hr.of
   Drug interactions: Enhanc.cephalospor.& aminoglycos. antibiot.  thes., impot., yell.vis., hypersens.reacts., cholest. jaund., pancre-  sleep. Restrict.water intake 1 hr bef.& 8 hrs.aft.admin. Short-
   nephrotoxic., phenytoin & indomethac. poss.reduc.clinic.effs., digit.  atit., bld.dyscras.  term treatm. period is 4-8 wks. Admin.recomm.dos.only once in 24 hrs.
   glycos. toxic. poss.enhnc., neuromusc.block.act.of competit. musc.re-  Special precautions: Imp.ren./hepat.funct., diabet., poss.hy-  CDI: Withdr.all prev.meds.& est.a baseline polyruria & polydipsia as
   lax.enhanc., antihypertens. agents effs.enhanc., K+-delet.eff.enhanc.  ponatraem.in sev.CHF where pts. are very oedemat.with high dos.  describ.in lit. Dose indiv. aft.test. Suggest.aveg.dos.obt.from prev.
   by corticoser./ corticotroph/carbenoxolone, tox.Li bld. lev., chang.in   in conjunct.with restrict. diet.salt, elderly pts.partic.suscept.to elec-  therapeut. results: Admin. 1-2x dly.intranasal. Childr: 0,05-0,1 ml
   antidiabet.agents.dos.poss.  trol. imbal., SLE may be exacerb/activ.in suscept. pts., Addisons dis.  (5-10 µg). Adults: 0,1-0,2 ml (10-20 µg).
                                Drug interactions: May enhanc.toxic.of digital. glycosides, enhanc.  Ren.conc.capacity test: Admin.as sngl.dos. Adults: 40 µg. Childr:
   RIDAQ, (Aspen Pharmacare: Pharma)    neuromusc.block.act.of competit. musc.relax., eff.of antihypertens.  &gt;1 yr: 20 µg. &lt;1 yr: 10 µg. Aft.admin.of DDAVP any urine collect.with
   Pharmacare                   agents poss. enhanc., postur.hypotens.poss.enhanc.by comcom. al-  1 hr.is discard. Dur.next 8 hrs.2 portions of urine are collected for os-
   Hydrochlorothiazide.         coh., barbitur./opoids,the K  deplet.eff. enhanc. by corticoster., corti-  molat.test. Restrict water intake.
                                            +
   Indications: Oed., essent.hypertens.in combinat. with other antihy-  cotrophin/ carbenoxolone, tox.Li bld.conc.  (S4) INTRANAS.SOL, [P/S] M/18.2/117. 0,1 mg/ml (1 dos =
   pertens., antidiuret.eff.in diab. insipid.                 0,1 ml(10 µg)
   (S3) TABS. M/18.1/35         SANDOZ SPIRONOLACTONE 25, Sandoz   717746-003: Multidose: 1x2,5 ml vial, R598,19
   880949-007: 25 mg, 500, R523,52  Spironolactone.           Dosage: Only.use where oral formulat.not feasible. Start at low.
   Dosage: Oed: Adults: Init.25-100 mg later reduc. to small.maint.dos.  Indications: Oed., ascites assoc.with hepat. cirrh., nephrot.  dos.& incr.progress.with caut. Admin.to childr.only und.adult su-
   oft.given on alt.days. An init. dos.of up to 200 mg may be necess.but   syndr., CCF.  pervis. Ren. conc.capac.test.in childr.und.1 yr.only to be perform.
   larg.dos. have no addit.eff.  (S3) TABS. Q/18.1/70.        in hosp.und.caref.supervis. Grad.plastic catheter (rhinyle) incl. See
   Hypertens: Adults: 25-100 mg/day with reduc. dos. of hypo-  769665-004: 25 mg, 30, R46,30  product lit for directs. for use.
   tens.agent.                  769665-012: 25 mg, 200, R312,20  CDI: Withdr.all prev.meds.& est.a baseline polyruria & polydipsia as
   Childr: 2,5 mg/kg bm dly.in 2 div.dos.  Dosage: Adults: 100 mg dly in 4 div.dose. Childr: 1,5-3 mg/kg bm dly.  describ.in lit. Dose indiv. aft.test. Childr: 0,05-0,1 ml (5-10 µg) 1-2xdly.
   (S3) TABS. A39/18.1/0399     Contraindications: Ac.ren.insuff., rapid.progr. ren.funct.impairm.,   Adults: 0,1-0,2 ml (10-20 µg) 1-2xdly.
   Indications: Mild to mod.hypertens.alone or in combinat.with   anur., hyperkalaem.  Ren.conc.capacity test: Recomm.sngl.dos: Adults: 40 µg. Childr.
   other antihypertens.         Side effects: Hyperkalaem., hyponatraem., drowsin., headache,   over 1 yr: 20 µg. Childr.und.1 yr: 10 µg. Discard.any urine collect.within
   710437-001: 12,5 mg, 30, R15,08  atax., maculopap/erythemat. cutan.erupts., impot., gynaecomast.,   1  hr.aft. admin. Dur.next 8 hrs.collect.2 urine portions for osmolality
                                                               st
   Dosage: If sngl.dos.indicat.pref.tak.in morn.to minim.freq.of urinat.  coma, mild androgen.eff.  test. Observ.water.intake restricts.
   dur.sleep. With /aft.meal.   Special precautions: Imp.ren.funct., hepat.dis., other K -spar.drugs/  Noct.enures: Clinic.eff.dos.range of 10-20 µg at hr.of sleep. Dos-
                                                       +
   Hypertens: Adults: 12,5 mg dly.  K -supplem., grad.withdr.  age should be est.progressiv. begin. with 10 µg dos. Max.dos.not
                                 +
   Adjunct in hypertens.: Adults: 12,5-25 mg dly.in conjunct.with anti-  Drug interactions: Eff.of antihypertens.agents enhanc.  to exceed 20 µg. Recomm.treatm.period 4-8 wks. Admin.only once
   hypertens.med. Dos. should not high.than necess.to achieve desir.eff.  in every 24 hrs. Restrict water intake 1 hr.bef. & 8 hrs. aft.admin.
   Contraindications: Ren./hepat.fail., Addisons’s dis., hypercal-  SPIRACTIN, (Aspen Pharmacare: Pharma) Pharmacare  (S4) TABS, [P/S] 29/18.2/0429, 34/18.2/0402
   caem., lactat., pregn.       Spironolactone.               Indications: Centr.diab.insipid., short-treatm.of prim. noct.enuresis
   Side effects: Metabol.disturbs., hyperglycaem., hyperuricaem., elec-  Indications: Oed., hypertens.  in childr.over 5 yrs. who have norm. ability to conc.urine.
   trol.imbal., hypochloraem. alkalos., hyponatraem., hypokalaem., re-  (S3) TABS. L/18.1/186, U/18.1/52  837563-003: 0,1 mg, 30, R540,64
   duc.urin. Ca excret., hypomagnesaem., GI disturbs., CNS effs., photos-  765910-004: 25 mg, 30, R45,30  703639-003: 0,2 mg, 30, R716,97
   ens.reacts., postur.hypotens., paraesthes., impot., yellow vis., hypers-  765910-012: 25 mg, 200, R302,00  Dosage: Indiv. Centr.diab.insipid: Adults & childr: 0,1 mg 3xdly.
   ens.reacts. incl skin reacts., cholestat.jaund., pancreatit., bld. dyscras.  898937-019: 100 mg, 60, R531,60  adjust.accord.to respons. Tot. dly.dos.varies betw. 0,2-1,2 mg. Optim.
   Special precautions: HF, restrict.diet.salt, imp. ren./hepat.funct.,   Dosage: Init.100 mg dly in 4 div.dos. Incr./decr. dos. accord.aft. 5   dos.regim: 0,1-0,2 mg 3xdly.
   diabet., monit.fluids/ electrol. bal., elderly, poss.exacerbat./activat.  days. Max. 400 mg dly. Concom. convent.diuret.if respon.unsatisf.
   of SLE, cross. placenta, distrib.into breastmilk, poss.K  ion loss with   Contraindications: Ac.ren.insuffic., anur., hyperkalaem., safety in   Noct.enures: Init. 0,2 mg at bedt.incr.up to 0,4 mg if low.dos.not
                         +
                                                              suffic.effect. Short-term treatm. period of 4-8 wks recomm. Admin.
                                          -
   prolong.use requir.supplementat.  pregn.not est., other K spar. diuret./K supplem.,
   Drug interactions: Toxic.of digital.glycosides enhanc., enhanc.  Side effects: Hyperkalaem., hyponatraem., CNS eff., skin reacts.,   recomm.dos. only once in 24 hrs. Do not use 0,1  & 0,2 mg tab in-
   neuromusc.block.act.of competit. musc.relax., potent.act.of other   impot., gynaecomast., androgen. eff.  terchangeably.
   antihypertens., alcoh., barbit., narcot.aggrav.postur.hypotens., K   +  Special precautions: Imp.ren.funct., sev.hepat. dis., monit.elec-  Contraindications: Nephrogen.diabet.insipid., safety in pregn.&
   deplet.eff.enhanc.by corticoster., corticotroph & beta 2-agonists, di-  trol.regul., withdr.grad., diab. mellit., pts.likely to develop acidos.  lactat.not est., periph.vasc.dis., CF/decomp.card.insuff., cirrhos., ne-
   minish.respons.to pressor amines, incr.Li tox.  Drug interactions: Enhanc.eff.of other antihypertens.  phrot.syndr./ chron.ren.dis., oed., hypertens., cerebr.vasc.dis., habit.&
                                                              psychogen. polydipsia, concom.diurets., hyponatraem., do not admin.
   RISAT, Aurobindo             UNAT, MEDA Pharma             to pts.with abnorm. ren.funct.for enures. Intranas.sol.& nas.spray
   Torasemide.                  Torasemide.                   also: SIADH, mod.to sev.ren.insuffic.
   Indications: Essent.hypertens., oed.of card.& hepat.origin, pulm.  Indications: Essent.hypertens., oed.of card.& hepat.origin, pulm.  Side effects: Sev.allerg.reacts., headache, emot. disturbs.in childr.,
   oed.due to ac.card.insuffic.  oed.due to ac.card.insuffic.  skin reacts., hypertens., trans. hypotens., tachycard., GI disturbs.,</code></pre>
     	</div>
    
     </div>
     <div id="content-bottom">
       <div id="content-bottom2">
         <table width="110" border="0" cellspacing="0" cellpadding="0">
           <tr>
             <td width="22%" height="44"><a href="page248.html"><img src="images/previous.png" width="26" height="19" id="Image2" onmouseover="MM_swapImage('Image2','','images/previous2.png',1)" onmouseout="MM_swapImgRestore()" /></a></td>
             <td width="43%">
             	&nbsp;&nbsp;&nbsp;<a href="page244.html">244</a>&nbsp;&nbsp;&nbsp;<a href="page245.html">245</a>&nbsp;&nbsp;&nbsp;<a href="page246.html">246</a>&nbsp;&nbsp;&nbsp;<a href="page247.html">247</a>&nbsp;&nbsp;&nbsp;<a href="page248.html">248</a>&nbsp;&nbsp;&nbsp;<a href="page249.html">249</a>&nbsp;&nbsp;&nbsp;<a href="page250.html">250</a>&nbsp;&nbsp;&nbsp;<a href="page251.html">251</a>&nbsp;&nbsp;&nbsp;<a href="page252.html">252</a>&nbsp;&nbsp;&nbsp;<a href="page253.html">253</a>&nbsp;&nbsp;&nbsp;<a href="page254.html">254</a>
             </td>
             <td width="35%"><a href="page250.html"><img src="images/next.png" width="26" height="19" id="Image1" onmouseover="MM_swapImage('Image1','','images/next2.png',1)" onmouseout="MM_swapImgRestore()" /></a></td>
           </tr>
         </table>
       </div>
     </div>
  </div>
</div>
<div id="right-button">
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p><a href="page250.html"><img src="images/next_big.png" width="90" height="80" /></a></p>
</div>


</div>

</body>
</html>
